
Abstract It has been suggested that the activation of the serotonin (5-hydroxytryptamine, 5-HT) receptor family 5-HT 2 , in particular the subtype 5-HT 2B , is a key step in the progression of drug-induced valvular heart disease (VHD). However, the localisation of 5-HT 2 receptors in human valves have not been reported. Thus, the current study investigated the regional and cellular localization of 5-HT 2 receptors in the tricuspid, mitral, aortic and pulmonary heart valves of six humans ( n = 24 samples) by immunohistochemistry post-mortem. We found that 5-HT 2A and 5-HT 2B receptors are present in all examined heart valves, whereas 5-HT 2C receptors were either not present or scarcely found. Interestingly, we found a uniform pattern of 5-HT 2B receptor numbers in all heart valves examined. Our results confirm patterns reported in echocardiographic investigations in patients with Parkinson’s disease treated with cabergoline and pergolide and suggest that the 5-HT 2 receptor located in heart valves may play a role in the drug-induced VHD.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
